Nasdaq

Cochlear announces FDA approval and FDA clearance of first-of-its-kind Remote Care capabilities for Nucleus and Baha Systems

LONE TREE, Colo., Oct. 12, 2021 /PRNewswire/ -- Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, obtained U.S. Food and Drug Administration (FDA) approval and clearance ...
Nasdaq

FDA expedites approval of Cochlear's Remote Check solution for cochlear implants

CENTENNIAL, Colo., April 7, 2020 /PRNewswire/ -- Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, obtained U.S. Food and Drug Administration (FDA) approval on April 2 ...
Pharmabiz

Cochlear receives US FDA nod for first remote programming option for cochlear implants

Cochlear Limited, the world leader in implantable hearing solutions, has received US Food and Drug Administration approval for the first remote feature to allow follow-up programming sessions for the ...
The Globe and Mail

Cochlear Limited’s Remote Care Study: A Potential Game-Changer in Hearing Implant Management

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Cochlear Limited is conducting a study ...